Synthetic Biologics and Intrexon have commenced development of a monoclonal antibody (mAb) therapy, SYN-005, to treat pertussis, commonly known as whooping cough. To manage the rising number of pertussis cases, Synthetic Biologics intends ...
Tags: Synthetic Biologics, monoclonal antibody therapy, whooping cough
Thermo Fisher Scientific, Inc and Immundiagnostik AG have announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial ...
Tags: Clinical Tools, Research Tools, clinical analysis, Mass Spectrometry
Successful cell culture relies on the maintenance of strict environmental conditions and scrupulous contamination control. Panasonic CO2 Incubators are designed to provide optimum conditions for cell culture and a hydrogen peroxide vapour ...
Tags: CO2 Incubators, cell culture, environmental conditions
Genmab has achieved a third pre-clinical milestone that generates a payment worth €1m as part of a collaboration with Lundbeck. The deal allows Genmab, which received €7.5m upfront payment previously, to develop human ...
Tags: Genmab, clinical trial, cooperation
Immunomedics has developed two new classes of bispecific antibodies, DOCK-AND-LOCK (DNL) complexes using its patented platform technology that enables site-specific conjugation of two self-assembling modules. The bispecific antibodies ...
Becton, Dickinson and Company (BD) has purchased a developer of polymer dyes used in flow cytometry, Sirigen Group. The acquisition will enable BD to expand its life science research reagent platform. BD Biosciences president Alberto ...
Thermo Fisher Scientific has entered into a definitive agreement to purchase One Lambda, a provider of transplant diagnostics services, for $925m in cash. One Lambda offers antibody detection assays that are used by transplant centers for ...
Tags: Thermo Fisher, agreement, purchase, One Lambda
Standards Council of Canada (SCC), a Canadian GLP monitoring authority, has granted good laboratory practice (GLP) certification to Wax-it Histology Services. Wax-it Histology Services is involved in providing general histopathology ...
Tags: Standards Council of Canada, GLP Certification, medical service
Clinical diagnostic tools manufacturer Bio-Rad Laboratories has agreed to buy AbD Serotec for €53m ($69.7m) in cash. The transaction, signed under the definitive agreement, is subject to certain closing conditions and is expected to ...
Tags: Clinical diagnostic tools, diagnostic tools, antibody, Bio-Rad
Prometheus Laboratories, a developer of diagnostic products, has introduced new Prometheus Anser infliximab (IFX) monitoring test. By utilizing the company's proprietary homogenous mobility shift assay (HMSA), the test measures infliximab ...
Tags: Prometheus, IFX, monitoring test, HMSA, IBD
pSivida, a developer of sustained release drug delivery products, has entered into an agreement with a biopharmaceutical company for the evaluation of its Tethadur protein/antibody delivery technology. Designed for use in the field of ...
Amorfix Life Sciences and CNJ Holdings have signed an agreement to identify and develop therapeutic antibodies targeting disease specific epitopes (DSEs). The collaboration will make use of Amorfix's ProMIS discovery technology and the ...
Tags: Amorfix Life Sciences, CNJ Holdings, agreement, disease specific epitopes
Janssen Biotech and Janssen Biologics are seeking approval for Stelara in the US and Europe for the treatment of active psoriatic arthritis. A supplemental biologics license application (sBLA) was submitted to the FDA and a Type II ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended conditional approval for Takeda Pharmaceuticals and Millennium adcetris (brentuximab vedotin) in Europe. If the CHMP ...
Tags: CHMP, refractory CD30 positive Hodgkin lymphoma, sALCL
Takeda Pharmaceutical Company and Millennium: The Takeda Oncology Company have won European conditional marketing authorization for Adcetris (brentuximab vedotin). Adcetris is indicated for use in adult patients with relapsed or ...
Tags: adcetris, antibody-drug conjugate, Brentuximab vedotin, sALCL